Advances in the natural α‐glucosidase inhibitors
eFood · 2023-10 · 4 (5)
DOI: 10.1002/efd2.112 ↗At a glance
Journal article in eFood, published online on 2023-09-12. Written by Didem Şöhretoğlu and 4 co-authors. Cited 35 times so far (Crossref); 107 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
α‐Glucosidase (AG) inhibitors, one of the classes of oral antidiabetics used to treat type 2 diabetes mellitus, delay digestion and absorption of glucose, which in turn, has a lowering effect on postprandial blood glucose and insulin levels. Natural products are a great source for the development of new AG inhibitory drug candidates. We aim to summarize advances in natural AG inhibitors according to their secondary metabolite groups in the last decade. Their mechanisms of action and structure–activity relationships will especially be discussed.
Cite
APA
Şöhretoğlu, D., Renda, G., Arroo, R., Xiao, J., & Sari, S. (2023). Advances in the natural α‐glucosidase inhibitors. eFood, 4(5). https://doi.org/10.1002/efd2.112
Vancouver
Şöhretoğlu D, Renda G, Arroo R, Xiao J, Sari S. Advances in the natural α‐glucosidase inhibitors. eFood. 2023;4(5). doi:10.1002/efd2.112
BibTeX
@article{hretolu2023,
author = {Şöhretoğlu, Didem and Renda, Gülin and Arroo, Randolph and Xiao, Jianbo and Sari, Suat},
title = {Advances in the natural α‐glucosidase inhibitors},
journal = {eFood},
year = {2023},
volume = {4},
number = {5},
doi = {10.1002/efd2.112}
}
EUVIMED